IDEXX Laboratories Inc. (IDXX)

190.27
NASDAQ : Health Technology
Prev Close 194.97
Day Low/High 189.58 / 193.75
52 Wk Low/High 154.88 / 256.22
Avg Volume 530.60K
Exchange NASDAQ
Shares Outstanding 86.23M
Market Cap 17.22B
EPS 3.00
P/E Ratio 52.41
Div & Yield N.A. (N.A)
The Fed Should Wait and See: Cramer's 'Mad Money' Recap (Thursday 12/13/18)

The Fed Should Wait and See: Cramer's 'Mad Money' Recap (Thursday 12/13/18)

Conflicting data about the economy should give the Federal Reserve pause.

Idexx Laboratories Becomes #45 Most Shorted Nasdaq 100 Component, Replacing Vertex Pharmaceuticals

Idexx Laboratories Becomes #45 Most Shorted Nasdaq 100 Component, Replacing Vertex Pharmaceuticals

The most recent short interest data has been released for the 11/30/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Bad News Is Good News: Cramer's 'Mad Money' Recap (Thursday 11/8/18)

Bad News Is Good News: Cramer's 'Mad Money' Recap (Thursday 11/8/18)

Cramer said the recent selloff has been good for investors because it reset expectations. Here's what he thinks about energy and the Fed.

Emerson Electric, Arista Networks, Foot Locker: 'Mad Money' Lightning Round

Emerson Electric, Arista Networks, Foot Locker: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Emerson Electric, Arista Networks, Foot Locker, SailPoint Technologies, Crown Holdings, Idexx Laboratories and more.

IDEXX Laboratories Announces Third Quarter Results

IDEXX Laboratories Announces Third Quarter Results

WESTBROOK, Maine, Nov. 1, 2018 /PRNewswire/ --   Reports revenue growth of 11% on a reported basis and 12% on an organic basis, driven by CAG Diagnostics recurring revenue growth of 12% reported and 13% organic    Delivers EPS of $1.

The Rally We've Been Waiting For: Cramer's 'Mad Money' Recap (Tuesday 10/16/18)

The Rally We've Been Waiting For: Cramer's 'Mad Money' Recap (Tuesday 10/16/18)

Panic is not an investment strategy, says Jim Cramer. But when everyone else is panicking, that's when you need to buy.

Behind the Selloff: Cramer's 'Mad Money' Recap (Thursday 10/11/18)

Behind the Selloff: Cramer's 'Mad Money' Recap (Thursday 10/11/18)

Jim Cramer's big takeaways? From cars and homebuilders to chips, he sees pockets of dramatic slowing.

The Bears Have it Backwards: Cramer's 'Mad Money' Recap (Monday 9/24/18)

The Bears Have it Backwards: Cramer's 'Mad Money' Recap (Monday 9/24/18)

Jim Cramer says traders hate hearing about long-term investing because they want instant payoffs.

PayPal, Senseonomics, Idexx Laboratories: 'Mad Money' Lightning Round

PayPal, Senseonomics, Idexx Laboratories: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at PayPal, Senseonomics, Idexx Laboratories, Sonos, Denbury Resources, Apptio, Invitae, Wayfair, JD.com, and McDonald's.

The Truth About Trade: Cramer's 'Mad Money' Recap (Monday 9/17/18)

The Truth About Trade: Cramer's 'Mad Money' Recap (Monday 9/17/18)

Jim Cramer says Wall Street isn't very worried about tariffs. He highlights the stocks with China exposure and looks at the potential impact.

IDEXX Labs, Evolent Health, Triton: 'Mad Money' Lightning Round

IDEXX Labs, Evolent Health, Triton: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at IDEXX Labs, Evolent Health, Triton, Western Gas Partners, Zimmer Biomet and more.

When Sellers Walk Away: Cramer's 'Mad Money' Recap (Tuesday 7/31/18)

When Sellers Walk Away: Cramer's 'Mad Money' Recap (Tuesday 7/31/18)

Jim Cramer says the tide of selling eventually ebbs, and when it does, stocks rally.

Market's Leap of Faith: Cramer's 'Mad Money' Recap (Wednesday 8/8/18)

Market's Leap of Faith: Cramer's 'Mad Money' Recap (Wednesday 8/8/18)

Jim Cramer talks about which companies and CEOs are being given the benefit of the doubt -- and which actually deserve it.

Putting IDEXX Laboratories Stock Under the Microscope

Putting IDEXX Laboratories Stock Under the Microscope

After the recent decline, let's see what the charts look like and if there are any signals.

How TheStreet's Editors Would Play the Market Volatility

How TheStreet's Editors Would Play the Market Volatility

U.S. Stocks are set for the strongest gains in six months as global markets rebound. TheStreet's editors give some advice for investors trying to navigate the wild ride.

There Was Change in the Air Today

The narrative is shifting which means the complacency is getting squeezed out of the market.

IDEXX Laboratories To Release 2018 Third Quarter Financial Results

IDEXX Laboratories To Release 2018 Third Quarter Financial Results

WESTBROOK, Maine, Sept. 24, 2018 /PRNewswire/ -- IDEXX Laboratories, Inc.

IDEXX Pseudalert Test Accepted As Global ISO Standard

IDEXX Pseudalert Test Accepted As Global ISO Standard

WESTBROOK, Maine, Sept. 10, 2018 /PRNewswire/ -- IDEXX Laboratories, Inc.

IDEXX Laboratories To Present At Bank Of America Merrill Lynch Global Healthcare Conference

IDEXX Laboratories To Present At Bank Of America Merrill Lynch Global Healthcare Conference

WESTBROOK, Maine, Sept. 5, 2018 /PRNewswire/ --  IDEXX Laboratories, Inc.

IDEXX Reference Laboratories Significantly Expands Rapid Overnight Service For Thousands Of U.S. Veterinary Practices

IDEXX Reference Laboratories Significantly Expands Rapid Overnight Service For Thousands Of U.S. Veterinary Practices

WESTBROOK, Maine, Aug. 15, 2018 /PRNewswire/ -- IDEXX Laboratories, Inc.

Idexx Laboratories Becomes #38 Most Shorted Nasdaq 100 Component, Replacing Monster Beverage

Idexx Laboratories Becomes #38 Most Shorted Nasdaq 100 Component, Replacing Monster Beverage

The most recent short interest data has been released for the 07/31/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

IDEXX Laboratories Is Not Responding to Bullish News

IDEXX Laboratories Is Not Responding to Bullish News

Let's review all our charts and indicators.

Idexx Laboratories Moves Up In Analyst Rankings, Passing Constellation Brands

Idexx Laboratories Moves Up In Analyst Rankings, Passing Constellation Brands

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Idexx Laboratories, Inc. has taken over the #47 spot from Constellation Brands Inc , according to ETF Channel.

IDEXX Laboratories To Host 2018 Investor Day

IDEXX Laboratories To Host 2018 Investor Day

WESTBROOK, Maine, Aug. 6, 2018 /PRNewswire/ --  IDEXX Laboratories, Inc.

IDEXX Laboratories Has Been a Real Keeper But a Correction Could Be Coming

IDEXX Laboratories Has Been a Real Keeper But a Correction Could Be Coming

Let's check the indicators and charts.

3 Great Stocks to Buy If You Love Your Pet

3 Great Stocks to Buy If You Love Your Pet

The animal health market continues to be strong, and so is the outlook. Here are several plays on the space and why you should make them.

Jim Cramer: 4 Pet-Related Stocks That Are Top Dog

Jim Cramer: 4 Pet-Related Stocks That Are Top Dog

The humanization of pets theme is driving outstanding earnings and share price growth for these 4 names.

IDEXX Laboratories Announces Second Quarter Results

IDEXX Laboratories Announces Second Quarter Results

WESTBROOK, Maine, Aug. 1, 2018 /PRNewswire/ --  Reports revenue growth of 14% on a reported basis and 12% on an organic basis, driven by CAG Diagnostics recurring revenue growth of 15% reported and 13% organic Achieves 3,241 premium instrument placements,...

IDEXX Laboratories To Release 2018 Second Quarter Financial Results

IDEXX Laboratories To Release 2018 Second Quarter Financial Results

WESTBROOK, Maine, July 5, 2018 /PRNewswire/ --  IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled the release of its 2018 second quarter financial...

Idexx Laboratories Becomes #44 Most Shorted Nasdaq 100 Component, Replacing Illumina

Idexx Laboratories Becomes #44 Most Shorted Nasdaq 100 Component, Replacing Illumina

The most recent short interest data has been released for the 06/15/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

TheStreet Quant Rating: B- (Buy)